Xenon Pharmaceuticals Inc. (XENE) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-09

Xenon Pharmaceuticals Inc. (XENE) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-09. 2 Form 8-K material event filings were reported by XENE in the last 90 days. 2 Form 144 notices of proposed sale were filed for XENE stock. InsiderAlpha tracks every XENE SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Xenon Pharmaceuticals Inc. (XENE)

SIC classificationPharmaceutical Preparations (SIC 2834)
SEC CIK0001582313

90-Day SEC Filing Activity

Form 4 filings (90d)10
Form 8-K filings (90d)2
Form 144 notices (90d)2
Latest Form 4 filing2026-06-09

Recent XENE Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Cannon GillianInsiderS — Open-market sale1.2K$53.14$63KSEC
PATOU GARYInsiderS — Open-market sale1.3K$53.14$70KSEC
GANNON STEVENInsiderM — Option exercise2.6K——SEC
Gover Justin D.InsiderM — Option exercise2.6K——SEC
Svoronos DawnInsiderM — Option exercise2.6K——SEC
Cannon GillianInsiderM — Option exercise2.6K——SEC
GANNON STEVENInsiderF — Tax withholding / forfeiture1.4K$53.41$76KSEC
GAROFALO ELIZABETH A.InsiderM — Option exercise2.6K——SEC
Svoronos DawnInsiderF — Tax withholding / forfeiture1.4K$53.41$76KSEC
PATOU GARYInsiderM — Option exercise2.6K——SEC
Machado PatrickInsiderM — Option exercise2.6K——SEC
GANNON STEVENInsiderM — Option exercise3.5K$7.38$26KSEC
DiFabio AndreaChief Legal OfficerS — Open-market sale [10b5-1]1.3K$55.23$74KSEC
MORTIMER IANPRESIDENT & CEOS — Open-market sale [10b5-1]7.3K$55.23$404KSEC
KENNEY CHRISTOPHER JOHNChief Medical OfficerS — Open-market sale [10b5-1]1.4K$55.23$78KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Xenon Pharmaceuticals Inc. (XENE). Updated in real time as new filings are submitted to the SEC.

Most-Active XENE Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
GANNON STEVEN7$101K
PATOU GARY5$70K
Svoronos Dawn5$76K
Cannon Gillian5$63K
Gover Justin D.4—

Recent XENE Form 8-K Material Events

Recent XENE Form 144 Notices of Proposed Sale

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in XENE insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

XENE Insider Trading — FAQ

What is the latest insider trade for XENE?
Xenon Pharmaceuticals Inc. (XENE) had 10 insider filings in the last 90 days, with the most recent on 2026-06-09. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying XENE stock?
0 insider purchases of XENE were filed in the last 90 days.
How many insiders are selling XENE stock?
0 insider sales of XENE were filed in the last 90 days.
Where can I see XENE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every XENE SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live XENE dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.